<?xml version="1.0" ?>
<document id="26578234">
  <sentence id="26578234.s0" text="In a bone metastasis model, epidermis development treated with ZOL+US had osteolytic lesions that were 58% smaller than those of ZOL-treated animals as well as a reduced skeletal tumor burden.">
    <entity charOffset="28-49" id="26578234.s0.e0" ontology_id="GO_0008544" text="epidermis development" type="GO"/>
    <entity charOffset="179-184" id="26578234.s0.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="26578234.s0.e0" e2="26578234.s0.e1" id="26578234.s0.p0" relation="true"/>
  </sentence>
  <sentence id="26578234.s1" text="Additionally, US forced the penetration of ZOL within tumors, as demonstrated by the intratumoral accumulation of unprenylated regulation of neurotransmitter receptor localization to postsynaptic specialization membrane, a surrogate marker of ZOL antitumor activity.">
    <entity charOffset="54-59" id="26578234.s1.e0" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <entity charOffset="127-219" id="26578234.s1.e1" ontology_id="GO_0098696" text="regulation of neurotransmitter receptor localization to postsynaptic specialization membrane" type="GO"/>
    <pair e1="26578234.s1.e0" e2="26578234.s1.e1" id="26578234.s1.p0" relation="true"/>
  </sentence>
</document>
